Article info
PDFReview
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
- Correspondence to Professor Karel Moons, Julius Center for Health Sciences and Primary Care, UMC Utrecht, PO Box 85500; 3508 GA Utrecht. The Netherlands; k.g.m.moons{at}umcutrecht.nl
Citation
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
Publication history
- Received December 13, 2011
- Accepted January 14, 2012
- First published March 7, 2012.
Online issue publication
May 30, 2016
Article Versions
- Previous version (30 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.